Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.0B | 2.1B | 2.1B | 1.8B |
Cost of revenue | 2.0B | 1.3B | 1.3B | 1.1B |
Gross profit | 1.1B | 783.2M | 764.2M | 665.9M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 232.5M | 36.7M | 97M | 55.9M |
Other operating expenses | 526M | 430.1M | 440.1M | 391.1M |
Operating income | -97M | 88.7M | 6.3M | 7.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.8M | 2.3M | 4.8M | 7.4M |
Other income expense | — | — | — | — |
Pretax income | -1.5B | 52.3M | 2.1M | 2.8M |
Tax provision | -372.9M | 13.2M | 1.6M | 800K |
Net income | -1.1B | 39.1M | 500K | 2M |
Basic EPS | — | 1.6 | 0.0 | 0.1 |
Diluted EPS | — | 1.6 | 0.0 | 0.1 |
Basic average shares | — | 24.3M | 25M | 25M |
Diluted average shares | — | 24.3M | 25M | 25M |
EBITDA | 12.5M | 147.7M | 62.1M | 63.8M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |